Efficacy and safety of restarting antiplatelet therapy for patients with spontaneous intracranial haemorrhage: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13377
Abstract: The benefits and risks of restarting antiplatelet therapy (APT) for patients with spontaneous intracranial haemorrhage (ICH) remain controversial. This meta‐analysis was performed to explore the efficacy and safety of restarting APT for these patients. read more here.
Keywords: restarting antiplatelet; antiplatelet therapy; intracranial haemorrhage; spontaneous intracranial ... See more keywords